Infectious Disease Vaccine

Varicella virus vaccine effective over long term

Published in TB and Outbreaks Week, April 16th, 2002

by Michael Greer, senior medical writer - The varicella-zoster virus (VZV) vaccine provides long-term protection from severe chickenpox, researchers in the United States report.

"The varicella vaccine was approved in 1995 for use in healthy varicella-susceptible children and adults," according to Dr. Krow Ampofo and colleagues at Columbia University in New York City.

People who participated in varicella vaccine trials as children maintained protection from chickenpox into adulthood, Ampofo and coauthors found.

They examined more than 460 healthy adults who were involved in clinical trials of live, attenuated VZV vaccines as early...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-04-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry